AnnualReportAI — Business Intelligence
UnitedHealth Group Inc. company mark

UnitedHealth Group Inc. Business Intelligence Report

Latest Annual Report • Financial Analysis • Management Commentary • Earnings Summary • Official Filings
Official Annual + Quarterly Filings · AI Business Intelligence
NASDAQ/NYSE: UNH
Sector: Healthcare
Industry: Healthcare Plans
Source: SEC EDGAR
Last Updated: 09 Jun 2026
Business Intelligence Report Verdict
High
Outlook: Positive
Peer Comparison Intelligence™
Compare UnitedHealth Group Inc. side by side with up to 3 similar peers
Compare Peers →

Executive Cockpit

AI Business Verdict™
High
Business quality, not a recommendation
Valuation Stance
—
Valuation not yet available
Latest Quarter
—
No scored quarter yet
FII Holding
—
Not available for US

Latest Quarterly Earnings Summary

No quarterly summary available yet.

Executive Brief

You're viewing a short preview. The full Business Intelligence Report covers 20+ in-depth sections.

Sign In for the Full Report

AI Summary

UnitedHealth Group (UNH) has demonstrated exceptional long-term compounding, growing revenue from $184.8B in 2016 to over $447B in 2025. The company operates a unique dual-engine model where Optum (health services) provides high-margin diversification against the cyclicality of UnitedHealthcare (insurance). Despite significant legal and impairment headwinds in 2024-2025, including the South America divestiture and Change Healthcare cyberattack impacts, the core business remains fundamentally robust. UNH maintains a dominant market share in Medicare Advantage and employer-sponsored plans. Its…

Key Changes in FY2026

Over the last decade, UNH has successfully transitioned from a traditional health insurer into a diversified healthcare technology and service powerhouse. The evolution is marked by the massive scaling of Optum, which now contributes a significant portion of total revenue and a majority of earnings growth. From 2016 to 2025, the company shifted focus toward 'value-based care,' where OptumHealth manages patient outcomes rather than just processing claims. The acquisition of Change Healthcare in 2022 marked a pivotal move into the data-backbone of the entire US healthcare infrastructure. Geographic expansion into South America (Amil) provided some diversification, though domestic healthcare technology remains the core priority. The recent integration of home health services (LHC Group)…

Management Commentary

Management has transitioned smoothly through several leadership changes, maintaining a consistent focus on 'value-based care' and technological integration. The leadership team demonstrates deep experience in navigating the complex US regulatory environment and CMS (Centers for Medicare & Medicaid Services) reimbursement shifts. Transparency is generally high, though the timing of the South American divestiture and the disclosure of the Change Healthcare cyber-impact costs tested management's ability to communicate complex headwinds. Their focus on long-term 13-16% EPS growth targets persists despite short-term fluctuations. The vision to move Optum into the home-care and pharmacy benefit management (PBM) spaces has successfully diversified the revenue stream away from pure insurance risk.

Financial Highlights

UNH's revenue growth is classified as 'Excellent,' maintaining a double-digit CAGR over the decade fueled by both organic growth and strategic acquisitions like Change Healthcare and LHC Group. Operating margins remained stable near 8-9% until the 2024-2025 period, where statutory net income was pressured by a $7B charge related to the Brazil business sale and regulatory headwinds. EBITDA and operating income had shown consistent linear progression, peaking in 2023. The 2024 per-share earnings drop to $15.64 from $24.12 marks a significant deviation caused by specific litigation and divestiture losses. However, the top-line expansion continues unabated, suggesting that the earning power of the enterprise remains intact for the 2026 recovery.

Impact Balance

Tailwinds Outweigh Headwinds
Positive weightage 56%Negative weightage 44%

Top 5 Positives

  • Strong historical Cash Conversion ratios until 2023

    High · 73 · Cash Flow
  • Consistent double-digit revenue growth over 10 years

    High · 71 · Growth
  • Dominant market share in Medicare Advantage

    High · 67 · Market Position
  • Optum segment continues to diversify revenue away from insurance premiums

    Moderate · 64 · Growth
  • Massive scale allows for industry-leading cost advantages

    Low · 39 · General

Top 5 Negatives

  • Rising Medical Care Ratio (MCR) impacting insurance profitability

    High · 70 · Profitability
  • Heavy reliance on government reimbursement rates (CMS)

    Moderate · 50 · Regulatory/Macro
  • Significant net income deterioration in 2024-2025

    Moderate · 47 · General
  • Massive non-recurring charge from Brazil operations exit

    Low · 41 · General
  • Vulnerability to large-scale cyberattacks (Change Healthcare incident)

    Low · 40 · General

Inside the Full Intelligence Dossier · 20+ Sections

A preview of what the complete report analyses for this company.

Forensic Red Flags
Related-party, auditor and accounting quality checks
Multi-Model Fair Value
DCF, earnings power, asset & relative models
Cash Flow Bridge
CFO vs profit, capex and free cash conversion
Governance Scorecard
Board, promoter pledge and disclosure quality
Moat & Competitive Edge
Pricing power, share and durability
Management Track Record
Guidance vs delivery over the years

About UnitedHealth Group Inc.'s Annual Report & Financial Performance

The latest UnitedHealth Group Inc. annual report (FY2026) is the company's flagship annual disclosure, filed with SEC EDGAR. It covers the full-year business review, management discussion & analysis, audited financial statements, the director's report, the corporate governance and auditor's reports, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This Business Intelligence Hub consolidates the official filings with AI-generated financial analysis so investors can see how revenue, operating margin, cash flow quality, capex, dividends, net debt and management outlook have changed — without reading the entire filing.

What this UnitedHealth Group Inc. research covers

  • Fundamental & business analysis
  • Financial statements & performance
  • Management commentary & discussion
  • Corporate governance & auditor report
  • Cash flow analysis & capital allocation
  • Valuation analysis & business quality
  • Growth analysis & competitive position
  • Risk, SWOT & moat analysis
  • Quarterly earnings & conference-call summary
  • Sector, industry & peer comparison
  • Latest official company filings
  • Business outlook & long-term growth

UnitedHealth Group Inc. — Frequently Asked Questions

Explore more UnitedHealth Group Inc. research

AI Top Insights — Premium

Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.